A case of hypocomplementemic urticarial vasculitis syndrome successfully treated with omalizumab

Nucera E, Basta F, Buonomo A, Mezzacappa S, Margiotta D, Antonelli Incalzi R, Schiavino D

J Investig Allergol Clin Immunol · 2017

Grade Ccase report
PubMed ↗

Key Findings

  • ●First report of successful omalizumab treatment for HUVS
  • ●Improvement in urticarial symptoms with anti-IgE therapy

Referenced in (1 disease)

Hypocomplementemic Urticarial Vasculitis Syndrome
ID: pmid-29199964PMID: 29199964